abstract |
The present invention relates to novel heterocyclic compounds which are antagonists of the melanin concentration hormone receptor 1 (MCHR1), also referred to as 11CBy, in pharmaceutical compositions containing them, in processes for their preparation, and in their use in medicaments. The compounds of the invention have the formula (I). |